Regulatory T Cells Boost Efficacy of Post-Infarction Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cell Transplants
Cells · 2025
DOI: 10.3390/cells14130956 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Aline Derisio de Lima und 11 weiteren Autor:innen. Beteiligte Einrichtung: Integrative Physiopathology and Therapeutics of Cardiovascular Diseases, University of Paris Cité, INSERM Unit 970, Paris Cardiovascular Research Cen…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Myocardial Infarction, Pluripotent Stem Cells, Stem Cell Transplantation. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca (Sweden), LABEX REVIVE.
Abstract (Originalsprache)
Cell therapy is promising for heart failure treatment, with growing interest in cardiovascular progenitor cells (CPCs) from pluripotent stem cells. A major challenge is managing the immune response, due to their allogeneic source. Regulatory T cells (Treg) offer an alternative to pharmacological immunosuppression by inducing immune tolerance. This study assesses whether Treg therapy can mitigate the xeno-immune response, improving cardiac outcomes in a mouse model of human CPC intramyocardial transplantation. CPCs stimulated immune responses in allogeneic and xenogeneic settings, causing proliferation in T cell subsets. Tregs showed immunosuppressive effects on T lymphocyte populations when co-cultured with CPCs. Post infarction, CPCs were transplanted intramyocardially into an immune-competent mouse model 3 weeks after myocardial infarction. Human or murine Tregs were intravenously administered on transplantation day and three days later. Control groups received CPCs without Tregs or saline (PBS). CPCs with Tregs improved LV systolic function in three weeks, linked to reduced myocardial fibrosis and enhanced angiogenesis. This was accompanied by decreased splenocyte NK cell populations and pro-inflammatory cytokine levels in cardiac tissue. Treg therapy with CPC transplantation enhances cardiac functional and structural outcomes in mice. Though it does not directly avert graft rejection, it primarily affects NKG2D+ cytotoxic cells, indicating systemic immune modulation and remote heart repair benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Integrative Physiopathology and Therapeutics of Cardiovascular Diseases, University of Paris Cité, INSERM Unit 970, Paris Cardiovascular Research Center (PARCC), 56 Rue Leblanc, F-75015 Paris, France.
- Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43150 Mölndal, Sweden.
- Research and Early Development, Bioscience In Vivo, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43150 Mölndal, Sweden.
- Immunology Department, INSERM Unit 1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI), AP-HP, Sorbonne Université, Hôpital Pitié-Salpêtrière, 47-83 Bd de l'Hôpital, F-75013 Paris, France.
- Department of Cardiovascular Surgery, Hôpital Européen Georges Pompidou, 20 Rue Leblanc, F-75015 Paris, France.
ORCID-Profile: Hernán Gonzalez-King Garibotti, Qing-Dong Wang, Cecilia Graneli, Tania Incitti, Valérie Bellamy, Myriam Assal, Makoto Miyara, Jean-Sébastien Silvestre, Karin Jennbacken
Förderung
- AstraZeneca (Sweden)
- LABEX REVIVE
Zitieren
APA
de Lima, A. D., Garibotti, H. G., Wang, Q. D., Graneli, C., Incitti, T., Bellamy, V., Corrêa, M. E. A. B., Assal, M., Miyara, M., Silvestre, J. S., Jennbacken, K., & Menasché, P. (2025). Regulatory T Cells Boost Efficacy of Post-Infarction Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cell Transplants. Cells. https://doi.org/10.3390/cells14130956
Vancouver
de Lima AD, Garibotti HG, Wang QD, Graneli C, Incitti T, Bellamy V, et al. Regulatory T Cells Boost Efficacy of Post-Infarction Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cell Transplants. Cells. 2025. doi:10.3390/cells14130956
BibTeX
@article{deLima2025,
author = {de Lima, Aline Derisio and Garibotti, Hernán Gonzalez-King and Wang, Qing-Dong and Graneli, Cecilia and Incitti, Tania and Bellamy, Valérie and Corrêa, Maria Eduarda Anastácio Borges and Assal, Myriam and Miyara, Makoto and Silvestre, Jean-Sébastien and Jennbacken, Karin and Menasché, Philippe},
title = {Regulatory T Cells Boost Efficacy of Post-Infarction Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cell Transplants},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14130956}
}
EUVIMED